PR interval. Cardiac arrhythmia, unspecified
Conditions
Interventions
Intervention group: Patients who are candidates for Functional Endoscopic Sinus Surgery (FESS) and rhinoplasty will be included in this group. All patients will receive 300 µg of oral clonidine (appr
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: patients who age more than 20 patients with ASA class I , II The patients should have a negative history of using Clonidine, psychotropic drugs, and beta-blockers Negative history of gastrointestinal disorders normal levels of serum creatinine All patients who will be candidates for Functional Endoscopic Sinus Surgery (FESS) or rhinoplasty
Exclusion criteria
Exclusion criteria: Patients who have a history of cardiovascular disorders will be excluded from the study. Patients who have a history of coagulation disorders will be excluded from the study. Patients who have a surgical duration exceeding 240 minutes will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of Clonidine on PR interval. Timepoint: The Clonidine will be administered 30 minutes before surgery. Six hours after the operation, a 12-lead ECG will be obtained from each patient and compared with the previously obtained ECG. Method of measurement: By utilizing the formulas from Fridericia and Framingham in the Electrocardiographic assessment of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSogol Asgari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed